Cargando…
The first Canadian experience with the Afirma® gene expression classifier test
BACKGROUND: Thyroid nodules are common and often benign, although prove to be malignant upon surgical pathology in 5–15% of cases. When assessed with ultrasound-guided fine-needle aspiration (USFNA), 15–30% of the nodules yield an indeterminate result. The Afirma® gene expression classifier (AGEC) w...
Autores principales: | Kay-Rivest, Emily, Tibbo, Jamie, Bouhabel, Sarah, Tamilia, Michael, Leboeuf, Rebecca, Forest, Veronique-Isabelle, Hier, Michael P., Savoury, Loren, Payne, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379689/ https://www.ncbi.nlm.nih.gov/pubmed/28372589 http://dx.doi.org/10.1186/s40463-017-0201-7 |
Ejemplares similares
-
The McGill Thyroid Nodule Score’s (MTNS+) role in the investigation of thyroid nodules with benign ultrasound guided fine needle aspiration biopsies: a retrospective review
por: Khalife, Sarah, et al.
Publicado: (2016) -
The T4/T3 quotient as a risk factor for differentiated thyroid cancer: a case control study
por: Sasson, Mark, et al.
Publicado: (2017) -
Medical Management for the Treatment of Nontuberculous Mycobacteria Infection of the Parotid Gland: Avoiding Surgery May Be Possible
por: Kay-Rivest, Emily, et al.
Publicado: (2016) -
A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery?
por: Al Jassim, Abrar, et al.
Publicado: (2018) -
Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer
por: Turkdogan, Sena, et al.
Publicado: (2018)